The antitumorigenic trifecta.

Published

Journal Article

The laboratory of Judah Folkman identified the potent endogenous antiangiogenic protein angiostatin in 1994.(1) In this issue of Blood, Lee and colleagues propose 2 new mechanisms of action for angiostatin that may represent promising targets for new cancer therapeutics.(2).

Full Text

Duke Authors

Cited Authors

  • Mowery, YM; Pizzo, SV

Published Date

  • August 27, 2009

Published In

Volume / Issue

  • 114 / 9

Start / End Page

  • 1727 - 1728

PubMed ID

  • 19713480

Pubmed Central ID

  • 19713480

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2009-06-226233

Language

  • eng

Conference Location

  • United States